Redmile-Group

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
56
Total Value
1057997904
Accession Number
0001104659-25-049578
Form Type
13F-HR
Manager Name
Redmile-Group
Data Enrichment
100% identified
56 identified0 unidentified

Holdings

56 positions
Manager:
Search and click to pin securities to the top
Page 2 of 3
ESTABLISHMENT LABS HOLDINGS INC.
Shares:335.4K
Value:$13.7M
Annexon, Inc.
Shares:6.3M
Value:$12.2M
Celldex Therapeutics, Inc.
Shares:590.2K
Value:$10.7M
FATE THERAPEUTICS INC
Shares:12.9M
Value:$10.2M
IDEAYA Biosciences, Inc.
Shares:534.6K
Value:$8.8M
Immunovant, Inc.
Shares:490.4K
Value:$8.4M
Ceribell, Inc.
Shares:435.2K
Value:$8.4M
RAPT Therapeutics, Inc.
Shares:6.5M
Value:$7.9M
Solid Biosciences Inc.
Shares:2.0M
Value:$7.5M
INSULET CORP
Shares:27.1K
Value:$7.1M
BioNTech SE
Shares:73.1K
Value:$6.7M
Silence Therapeutics plc
Shares:2.2M
Value:$6.2M
Penumbra Inc
Shares:22.8K
Value:$6.1M
iRhythm Technologies, Inc.
Shares:56.8K
Value:$6.0M
Keros Therapeutics, Inc.
Shares:552.5K
Value:$5.6M
Verve Therapeutics, Inc.
Shares:1.2M
Value:$5.5M
Nuvation Bio Inc.
Shares:3.0M
Value:$5.3M
Shattuck Labs, Inc.
Shares:5.5M
Value:$5.3M
MASIMO CORP
Shares:26.1K
Value:$4.3M
Prime Medicine, Inc.
Shares:2.1M
Value:$4.1M